The National Legislative Association on Prescription Drug Prices is disbanding in large part because the organization achieved its goals, a release from the group states, but the break up happens as plans and providers fight against high prices of specialty drugs. Sharon Treat, the group's executive director, said problems remain on drug pricing, but there is less need for the group. With so many people covered, there will be a lot more pressure from taxpayers and plans to keep prices...